TCL Archive NCI Treatment Division To Recompete $10 Million In Resource Contracts; Board Okays New Projects November 12, 1976
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive Cancer Policy: EMFs “Possible” Carcinogen, Panel Says; Plans Public Hearings August 7, 1998